Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00225992
Status:
TERMINATED
Last Update Posted:
2012-10-11
First Post:
2005-09-22
Brief Title:
Phase II Research Study of Arsenic Trioxide Trisenox in Patients With Myelodysplastic Syndrome MDS
Sponsor:
Oncology Specialties Alabama
Organization:
Oncology Specialties Alabama
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome MDS |
Keywords: